Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Melbourne
Clinical trial register · Australia

Clinical Trials in Melbourne, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3343 matching records held by the registry are in this view. Synced 15 Oct 2026, 03:18 UTC
3343
Studies in scope
all four open statuses
1804
Recruiting now
open to new participants
765
Lead sponsors
across recruiting studies
Top sites
Melbourne 20 Camperdown 10 Parkville 8 Westmead 8 Woolloongabba 7
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Trials with a site in Melbourne

20 of 3343 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Recruiting
Pfizer
Phase 3
800
Buderim, Woodville South, Hobart, Clayton, Melbourne
2025-12-11
Active, closed
Pfizer
Phase 3
1,035
Douglas, Woolloongabba, Capel Sound, Melbourne, Parkville
2025-01-06
Active, closed
Pfizer
Phase 3
600
Auchenflower, Clayton, Melbourne
2024-10-21
Active, closed
Pfizer
Phase 3
394
Darlinghurst, Campbelltown, Carlton, East Melbourne, Melbourne
2024-01-19
Active, closed
Pfizer
Phase 3
1,571
Phillip, Kogarah, St Leonards, Woolloongabba, Campbelltown, Woodville South, East Melbourne, Melbourne
2023-11-08
Recruiting
Pfizer
Phase 4
80
Melbourne, Richmond
2023-10-03
Recruiting
Pfizer
Phase 3
173
Camperdown, Melbourne
2022-12-28
Active, closed
Pfizer
Phase 1
148
Melbourne, Parkville
2022-11-30
Recruiting
Pfizer
Phase 2
91
Liverpool, Mount Kuring-Gai, Waratah, Bedford Park, Kurralta Park, Melbourne, Perth
2022-02-02
Recruiting
Pfizer
Phase 3
245
Melbourne
2021-11-17
Recruiting
Pfizer
Phase 3
893
Benowa, Clayfield, Greenslopes, Woolloongabba, East Melbourne, Fitzroy, Geelong, Melbourne
2021-10-04
Recruiting
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
NCT04606446Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer
Pfizer
Phase 2
320
Camperdown, Adelaide, Melbourne, Parkville, St Albans, Subiaco
2020-11-16
Active, closed
Pfizer
Phase 3
51
Camperdown, Adelaide, Melbourne, Murdoch, Herston
2019-07-29
Active, closed
Pfizer
Phase 3
296
Bendigo, Melbourne
2017-04-27
Rows per page Showing 1–20 of 20
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 October 2026. https://priyalifescience.com/clinical-trials-australia/city/melbourne

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,343 studies in total at the last sync on 15 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 20 of those studies with a site in Melbourne that also match the filters currently applied.

How many clinical trials are recruiting in Melbourne?

10 of the 20 studies on this page are recruiting new participants as of the 15 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 10 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Melbourne), 20 studies
PhaseStudiesRecruitingShare
Phase 313665%
Phase 24220%
Phase 42210%
Phase 1105%

Most active sponsors

Lead sponsors with the most studies (Melbourne)
Lead sponsorStudiesRecruiting
Pfizer2010
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.